Table of Contents

2019-2024 Global Therapeutic Radioisotopes Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Therapeutic Radioisotopes Consumption 2014-2024
  • 2.1.2 Therapeutic Radioisotopes Consumption CAGR by Region
• 2.2 Therapeutic Radioisotopes Segment by Type
  • 2.2.1 Radium-223
  • 2.2.2 Lutetium-177
  • 2.2.3 Iodine-131
  • 2.2.4 Other
• 2.3 Therapeutic Radioisotopes Consumption by Type
  • 2.3.1 Global Therapeutic Radioisotopes Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2014-2019)
• 2.4 Therapeutic Radioisotopes Segment by Application
  • 2.4.1 Thyroid
  • 2.4.2 Bone Metastasis
  • 2.4.3 Lymphoma
  • 2.4.4 Other
• 2.5 Therapeutic Radioisotopes Consumption by Application
  • 2.5.1 Global Therapeutic Radioisotopes Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Therapeutic Radioisotopes Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2014-2019)

3 Global Therapeutic Radioisotopes by Players

• 3.1 Global Therapeutic Radioisotopes Sales Market Share by Players
  • 3.1.1 Global Therapeutic Radioisotopes Sales by Players (2017-2019)
  • 3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Players (2017-2019)
• 3.2 Global Therapeutic Radioisotopes Revenue Market Share by Players
  • 3.2.1 Global Therapeutic Radioisotopes Revenue by Players (2017-2019)
  • 3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Players (2017-2019)
• 3.3 Global Therapeutic Radioisotopes Sale Price by Players
• 3.4 Global Therapeutic Radioisotopes Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Therapeutic Radioisotopes Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Therapeutic Radioisotopes Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Radioisotopes by Regions

• 4.1 Therapeutic Radioisotopes by Regions
  • 4.1.1 Global Therapeutic Radioisotopes Consumption by Regions
  • 4.1.2 Global Therapeutic Radioisotopes Value by Regions
• 4.2 Americas Therapeutic Radioisotopes Consumption Growth
• 4.3 APAC Therapeutic Radioisotopes Consumption Growth
• 4.4 Europe Therapeutic Radioisotopes Consumption Growth
• 4.5 Middle East & Africa Therapeutic Radioisotopes Consumption Growth

5 Americas

• 5.1 Americas Therapeutic Radioisotopes Consumption by Countries
  • 5.1.1 Americas Therapeutic Radioisotopes Consumption by Countries (2014-2019)
  • 5.1.2 Americas Therapeutic Radioisotopes Value by Countries (2014-2019)
• 5.2 Americas Therapeutic Radioisotopes Consumption by Type
• 5.3 Americas Therapeutic Radioisotopes Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Therapeutic Radioisotopes Consumption by Countries
  • 6.1.1 APAC Therapeutic Radioisotopes Consumption by Countries (2014-2019)
  • 6.1.2 APAC Therapeutic Radioisotopes Value by Countries (2014-2019)
• 6.2 APAC Therapeutic Radioisotopes Consumption by Type
• 6.3 APAC Therapeutic Radioisotopes Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Therapeutic Radioisotopes by Countries
  • 7.1.1 Europe Therapeutic Radioisotopes Consumption by Countries (2014-2019)
  • 7.1.2 Europe Therapeutic Radioisotopes Value by Countries (2014-2019)
• 7.2 Europe Therapeutic Radioisotopes Consumption by Type
• 7.3 Europe Therapeutic Radioisotopes Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Therapeutic Radioisotopes by Countries
  • 8.1.1 Middle East & Africa Therapeutic Radioisotopes Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Therapeutic Radioisotopes Value by Countries (2014-2019)
• 8.2 Middle East & Africa Therapeutic Radioisotopes Consumption by Type
• 8.3 Middle East & Africa Therapeutic Radioisotopes Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Therapeutic Radioisotopes Distributors
• 10.3 Therapeutic Radioisotopes Customer

11 Global Therapeutic Radioisotopes Market Forecast

• 11.1 Global Therapeutic Radioisotopes Consumption Forecast (2019-2024)
• 11.2 Global Therapeutic Radioisotopes Forecast by Regions
  • 11.2.1 Global Therapeutic Radioisotopes Forecast by Regions (2019-2024)
  • 11.2.2 Global Therapeutic Radioisotopes Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Therapeutic Radioisotopes Forecast by Type
• 11.8 Global Therapeutic Radioisotopes Forecast by Application

12 Key Players Analysis

• 12.1 Bayer
  • 12.1.1 Company Details
  • 12.1.2 Therapeutic Radioisotopes Product Offered
  • 12.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer News
• 12.2 Novartis
  • 12.2.1 Company Details
  • 12.2.2 Therapeutic Radioisotopes Product Offered
  • 12.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Novartis News
• 12.3 China Isotope & Radiation
  • 12.3.1 Company Details
  • 12.3.2 Therapeutic Radioisotopes Product Offered
  • 12.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 China Isotope & Radiation News
• 12.4 Dongcheng
  • 12.4.1 Company Details
  • 12.4.2 Therapeutic Radioisotopes Product Offered
  • 12.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Dongcheng News
• 12.5 Q BioMed
  • 12.5.1 Company Details
  • 12.5.2 Therapeutic Radioisotopes Product Offered
  • 12.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Q BioMed News
• 12.6 Curium Pharmaceuticals
  • 12.6.1 Company Details
  • 12.6.2 Therapeutic Radioisotopes Product Offered
  • 12.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Curium Pharmaceuticals News
• 12.7 Jubilant DraxImage
  • 12.7.1 Company Details
  • 12.7.2 Therapeutic Radioisotopes Product Offered
  • 12.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Jubilant DraxImage News
• 12.8 Lantheus
  • 12.8.1 Company Details
  • 12.8.2 Therapeutic Radioisotopes Product Offered
  • 12.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Lantheus News
• 12.9 Spectrum Pharmaceuticals
  • 12.9.1 Company Details
  • 12.9.2 Therapeutic Radioisotopes Product Offered
  • 12.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Spectrum Pharmaceuticals News
• 12.10 Progenics Pharmaceuticals
  • 12.10.1 Company Details
  • 12.10.2 Therapeutic Radioisotopes Product Offered
  • 12.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Progenics Pharmaceuticals News
• 12.11 International Isotopes

13 Research Findings and Conclusion

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

According to this study, over the next five years the Therapeutic Radioisotopes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Radioisotopes business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Radioisotopes market by product type, application, key manufacturers and key regions and countries.

This study considers the Therapeutic Radioisotopes value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thyroid
Bone Metastasis
Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Therapeutic Radioisotopes consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Therapeutic Radioisotopes market by identifying its various subsegments.
Focuses on the key global Therapeutic Radioisotopes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Radioisotopes with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Radioisotopes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.